SAGES President Talks Sustainability
In this episode, Dr. Patricia Sylla, president of SAGES, discusses the society’s initiatives with sustainability and previews a few other important topics of their upcoming meeting.
In this episode, Dr. Patricia Sylla, president of SAGES, discusses the society’s initiatives with sustainability and previews a few other important topics of their upcoming meeting.
Video abstract of “Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a r…
Survival rates for esophageal squamous cell carcinoma (ESCC) are extremely low due to the late diagnosis of most cases. An understanding of the early molecular…
Objective Liver fibrosis is a prelude to a host of end-stage liver diseases. Hepatic stellate cells (HSCs), switching from a quiescent state to myofibroblasts, are…
Deaths from the majority of cancers are falling globally, but the incidence and mortality from hepatocellular carcinoma (HCC) is increasing in the United Kingdom and…
Guest Expert: Emanuele Lo Menzo, MD, PhD
Barrett’s oesophagus is the only known precursor to oesophageal adenocarcinoma, a cancer with very poor prognosis. The main risk factors for Barrett’s oesophagus are a…
Objective Elucidating complex ecosystems and molecular features of gallbladder cancer (GBC) and benign gallbladder diseases is pivotal to proactive cancer prevention and optimal therapeutic intervention.…
Jejunostomy tube placements provides enteral access for feeding in eligible patients who cannot meet their nutritional needs by mouth. They can be surgically placed laparoscopically…
Iatrogenic bile duct injury (BDI) during cholecystectomy is associated with a complex and heterogeneous management owing to the burden of morbidity until their definitive treatment.…
The FDA has approved the first multitarget stool RNA test for colorectal cancer screening in typical average-risk adults 45 years of age and older.